Nuveen Virginia Quality Municipal Income Fund (NPV) At $12.30 Forms Bottom; Eiger Biopharmaceuticals (EIGR) SI Increased By 71.52%

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Logo

Nuveen Virginia Quality Municipal Income Fund (NPV) formed multiple bottom with $11.56 target or 6.00% below today’s $12.30 share price. Nuveen Virginia Quality Municipal Income Fund (NPV) has $220.58 million valuation. The stock decreased 0.16% or $0.02 during the last trading session, reaching $12.3. About 14,210 shares traded. Nuveen Virginia Quality Municipal Income Fund (NYSE:NPV) has declined 4.72% since April 11, 2017 and is downtrending. It has underperformed by 16.27% the S&P500.

Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) had an increase of 71.52% in short interest. EIGR’s SI was 363,800 shares in April as released by FINRA. Its up 71.52% from 212,100 shares previously. With 352,100 avg volume, 1 days are for Eiger Biopharmaceuticals Inc (NASDAQ:EIGR)’s short sellers to cover EIGR’s short positions. The SI to Eiger Biopharmaceuticals Inc’s float is 5.89%. The stock increased 3.06% or $0.3 during the last trading session, reaching $10.1. About 42,798 shares traded. Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) has declined 11.57% since April 11, 2017 and is downtrending. It has underperformed by 23.12% the S&P500.

Eiger BioPharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on providing various products for the treatment of orphan diseases in the United States. The company has market cap of $106.32 million. The Company’s product candidate pipeline includes Lonafarnib for the treatment of hepatitis delta virus infection; PEG-interferon Lambda-1a (Lambda) for HDV infection; Exendin 9-39 for post-bariatric hypoglycemia; and Ubenimex for the treatment of pulmonary arterial hypertension and lymphedema, which are under Phase II clinical trials. It currently has negative earnings.

Investors sentiment increased to 2.17 in 2017 Q4. Its up 0.88, from 1.29 in 2017Q3. It is positive, as 1 investors sold Nuveen Virginia Quality Municipal Income Fund shares while 5 reduced holdings. 4 funds opened positions while 9 raised stakes. 899,159 shares or 16.60% more from 771,136 shares in 2017Q3 were reported. Raymond James Assoc reported 22,485 shares. Fiera Cap holds 0% of its portfolio in Nuveen Virginia Quality Municipal Income Fund (NYSE:NPV) for 58,565 shares. Wells Fargo & Mn invested 0% in Nuveen Virginia Quality Municipal Income Fund (NYSE:NPV). James Investment Research Inc reported 3,600 shares. Cambridge Inv Rech accumulated 12,834 shares. 37,260 are owned by Landscape Management Lc. Rmb Cap Ltd Limited Liability Company reported 32,339 shares stake. The Virginia-based Thompson Davis & Com has invested 0% in Nuveen Virginia Quality Municipal Income Fund (NYSE:NPV). Natl Bank Of America Corp De holds 0% in Nuveen Virginia Quality Municipal Income Fund (NYSE:NPV) or 69,434 shares. Hightower Limited Liability Corp reported 24,955 shares or 0% of all its holdings. Welch And Forbes has invested 0.01% in Nuveen Virginia Quality Municipal Income Fund (NYSE:NPV). Fifth Third Comml Bank holds 0% or 9,500 shares. Virginia-based Davenport And Ltd Limited Liability Company has invested 0.03% in Nuveen Virginia Quality Municipal Income Fund (NYSE:NPV). Wetherby Asset Mgmt Inc accumulated 21,642 shares. Thompson Siegel And Walmsley Limited Liability Corporation holds 10,923 shares or 0% of its portfolio.

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Ratings Chart